Volume 6, Issue 4, August 2018, Page: 30-42
On Branched Chain Processes, the Laws of Development of Which Are Expressed by Numerical Sequences Like Fibonacci Numbers, a New Look at Their Nature
Yurii Petrenko, Medical and Biological Faculty, Pirogov Russian National Research Medical University, Moscow, Russian Federation
Received: Jul. 23, 2018;       Accepted: Aug. 15, 2018;       Published: Oct. 11, 2018
DOI: 10.11648/j.sjc.20180604.11      View  291      Downloads  44
Abstract
Branched chain chemical reactions represent a special class of chemical transformation reactions of matter, for the discovery and experimental-theoretical development of which Semenov N. N. and Hinshelwood C. N. were awarded the Nobel Prize in 1956. In nature, such processes are widespread. Objective. To investigate the nature of various numerical sequences of the Fibonacci type and to find out under what conditions they can reflect (express) the patterns of development of branched chain processes. In this work, the state is formulated that branched chain chemical reactions are a particular case of branched chain processes of any nature in different spheres, including biological. It is shown that many branched chain processes can generate numerical sequences of Fibonacci, Lucas, Shannon and others of the same type, which reflect the dynamics of their development. For all the indicated numerical sequences, it is typical that their formation is determined by a general recurrent law, which has been the subject of research for many well-known mathematicians. For each of the indicated numerical sequences they established other laws alternative to the recurrent one, however, they were all of a private nature. They were in accordance with the recurrent law only in the case of one specific sequence. Comparative analysis of many numerical sequences allowed us to find a universal law that is common for all types of sequences and terminologically define it as the law of "doubling with subtraction." For all numerical series the formation of which follows a recurrent law, the law "doubling with subtraction" is equally valid. The opposite is not true since there are numerical sequences that obey only the law of "doubling with subtraction," and the recurrent law is not valid for them. It means that the new law is more fundamental and, in fact, is the primary law and the recurrent law is secondary. Significant differences also exist in the consequences of these two laws. For example, the increments of sequences formed according to the recurrent law and the law of "doubling with subtraction" have fundamental differences in their mathematical expression, although they lead in different ways to the same result, namely, to Ф = 1,618... with the serial numbers of the sequence terms tending to infinity. In the work for each of these laws, a branched chain biological process that was unique to it was found and put in correspondence. In the case of the law of "doubling with subtraction", the process was followed by the termination of chains with characteristic parameters: the chain length is three links, the branching factor is -2. In the case of a recurrent law, the process was without chain termination, with an infinite length and with a branching factor of -2, and with some delay limiting the branching. It seems interesting that such different branched chain processes of different character are described by the same Fibonacci sequence. The processes of branched chain character corresponding to the sequences of Lucas, Shannon, and others are discussed. Conclusions. According to our work, it follows that all formal mathematics, that is, all the mathematical features and patterns related to the Fibonacci sequence is just a description of those features and patterns that are inherent in the branched chain processes that actually produce these and other sequences.
Keywords
Branched Chain Processes, Numerical Sequences, Fibonacci Sequences, Lucas Numbers, Recurrent Formula
To cite this article
Yurii Petrenko, On Branched Chain Processes, the Laws of Development of Which Are Expressed by Numerical Sequences Like Fibonacci Numbers, a New Look at Their Nature, Science Journal of Chemistry. Vol. 6, No. 4, 2018, pp. 30-42. doi: 10.11648/j.sjc.20180604.11
Copyright
Copyright © 2018 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Penel N., Kramar A., 2012, What does a modified-Fibonacci dose-escalation actually correspond to?, Medical Research Methodology, 12, 103.
[2]
Zelen M., Theory and practive of clinical trials/ 2003, In Holland- Frei Cancer Medicine Ontario BC: Decker.
[3]
Barve M. Wang Z., Kumar P. at all/Phase 1 Trial of Bi-shRNA STMN1 BIV in Refractory Cancer/ Molecular Therapy 2015, 23, 6, 1123-1130.
[4]
Lim H. S., Bae K. S., Jng J. A., at all/ Predicting the efficacy of an oral paclitaxel formulation (DHP107) through modeling and simulation/ Clin. Ther. 2015, 37, (2), 402-417.
[5]
Orita M., Ohno K., Niimi T. Two “Golden Ratio” indices in fragment-based drug discovery/Drug Discovery Today, 2009, v. 14, №5/6, p. 321-328.
[6]
Congreve M., Chessari G, Tisi D., Woodhead J./ Resent Developments in Fragment-Based Drug Discovery/Journal of Medicinal Chemistry, 2008, v. 51, №13.
[7]
Jarvis G. E., Thompson A. J / A Golden approach to ion channel inhibition, 2013, Trendsin Pharmacological Sciences, v. 34, №9, p. 481-488.
[8]
Yamagishi M. E. B, Shimabucuro A. I./. Nucleotide Frequencies in Human Genome and Fibonacci Numbers /J. Mathematical Biology 2008, 70, 3, 643-653.
[9]
Forsdyke D. R., Bell S. J. /A discussion of the application of elementary principles to early chemical observations, /Applied Bioinformatics, 2004, 3, 3-8.
[10]
Gibson C. M., Gibson W. J., Murphy S. A., Marblt S. J., McCabe C. H., Turakhia M. P., Kirtane A. J., Karha J., Aroesty J. M., Giugliaano R. P., Antman E. M./ Association of the Fibonacci Cascade with the distribution of coronary artery lesions responsible for ST- segment elevation myocardial infarction/ Am. J. Cardiol., 2003, 1, 92 (5), 595-597.
[11]
Choo K. W., Quah W. K., Chang G. H., Chan J. Y./ Functional hand proportion is approximated by Fibonacci series/ Folia Morphol (Warsz), 2012, 71 (3), 148-153.
[12]
Marinkovic S., Stankovic P., Strbac M., Tomic I., Getkovic M. / Coclea and other spiral forms in nature and art/ Am. J. Otolaryngol. 2012, 33 (1), 80-87.
[13]
Visconti G., Visconti E, Bonomo L., Salgarello M./ Concepts in Navel Aesthetic: A Comprehensive Surface Anatomy Analysis/ Aesthetic Plast. Surg., 2015, 39 (1). 43-50.
[14]
Yeykin E., Topbas U., Yanik A., Yetkin G./ Does systolic and diastolicblood pressure follow Golden Ratio?/ Int. Cardiol. 2014, 176 (3), 1457-1459.
[15]
Stieger S., Swami V. /Time to let go? No automatic aesthetic preference for the golden ratio in art pictures/ Psychology of Aesthetics, Creativity, and the Arts, 2015, v. 9 (1).
[16]
Semenov, NN / On Chain Reactions and the Theory of Combustion, Izdatelstvo Znanie 1957, Series VIII, No. 17, Moscow,, p. 1-25; Advances of Chemistry 1957, v. 26, issue 3, p. 273-291).
[17]
Petrenko Yu. M., Vladimirov YA / Determination of the mechanism of action of antioxidants in lipid systems on the parameters of chemiluminescence in the presence of ferrous iron / Biophysics, 1976, vol. 21, №3, p. 424-427.
[18]
Titov V. Yu., Petrenko Yu. M., Petrov VA, Vladimirov Yu. A. / Mechanism of oxyhemoglobin oxidation induced by hydrogen peroxide / Byull. Exper. Biol, Medicine, 1991, Vol. 112, No. 7, 46-49.
[19]
Shannon A. G./ Generalized Fibonacci Matrices in Medicine/Notes on Number Theoryand Discrete Mathematics 15, 2009, 1, 12-21.
[20]
Iconaru EI, Georgescu L, Ciucurel C./ A mathematical modelling analysis of the response of blood pressure and heart rate to submaximal exercise./ Acta Cardiol. 2018 Jun 18:1-8.
[21]
Lee J, Kim ST, Park S, Lee S, Park SH, Park JO, Lim HY, Ahn H, Bok H, Kim KM, Ahn MJ, Kang WK, Park YS./ Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer./ Clin Colorectal Cancer. 2018 Jun; 17 (2):140-146.
Browse journals by subject